Exploring the Impact of Mental Health on PSA Screening: Insights From a Population-Based Survey.
설문조사
1/5 보강
[OBJECTIVE] To explore the relationship between mental health status and prostate-specific antigen (PSA) screening, given that poor mental health may reduce engagement in preventive health behaviors.
- p-value P <.001
APA
Piccolini A, Qian Z, et al. (2025). Exploring the Impact of Mental Health on PSA Screening: Insights From a Population-Based Survey.. Urology, 204, 112-120. https://doi.org/10.1016/j.urology.2025.06.016
MLA
Piccolini A, et al.. "Exploring the Impact of Mental Health on PSA Screening: Insights From a Population-Based Survey.." Urology, vol. 204, 2025, pp. 112-120.
PMID
40517823 ↗
Abstract 한글 요약
[OBJECTIVE] To explore the relationship between mental health status and prostate-specific antigen (PSA) screening, given that poor mental health may reduce engagement in preventive health behaviors.
[METHODS] We analyzed data from the 2018 and 2020 Behavioral Risk Factor Surveillance System surveys, including men aged 50-69 years without history of prostate cancer. The primary outcome was self-reported PSA screening in the past two years. Poor mental health was defined as at least 14 days of self-reported poor mental health or a depressive disorder diagnosis. Covariates included socio-demographic variables, chronic comorbidities, and healthcare access. Logistic regression assessed associations between mental health, PSA screening, and covariates.
[RESULTS] A total of 114,972 men were included, representing a weighted population of 30.5 million. Of them, 81.9% and 18.1% had good and poor mental health, respectively. The overall PSA screening rate was 28.2%. Men with good mental health were more likely to undergo PSA screening (29.3% vs 23.2%; P <.001). Poor mental health was associated with 10% lower odds of PSA screening (aOR: 0.90 [0.83-0.98]). Higher adherence was observed among older participants (aOR: 2.54), with higher education levels (aOR: 1.95), or married (aOR: 1.21). Having at least one personal doctor (aOR: 2.86) was a strong predictor of PSA screening.
[CONCLUSION] Men with poor mental health are less likely to undergo PSA screening. Addressing mental health barriers is essential to improve preventive care. Integrated care models with mental health support may reduce disparities and enhance prostate cancer outcomes in this population.
[METHODS] We analyzed data from the 2018 and 2020 Behavioral Risk Factor Surveillance System surveys, including men aged 50-69 years without history of prostate cancer. The primary outcome was self-reported PSA screening in the past two years. Poor mental health was defined as at least 14 days of self-reported poor mental health or a depressive disorder diagnosis. Covariates included socio-demographic variables, chronic comorbidities, and healthcare access. Logistic regression assessed associations between mental health, PSA screening, and covariates.
[RESULTS] A total of 114,972 men were included, representing a weighted population of 30.5 million. Of them, 81.9% and 18.1% had good and poor mental health, respectively. The overall PSA screening rate was 28.2%. Men with good mental health were more likely to undergo PSA screening (29.3% vs 23.2%; P <.001). Poor mental health was associated with 10% lower odds of PSA screening (aOR: 0.90 [0.83-0.98]). Higher adherence was observed among older participants (aOR: 2.54), with higher education levels (aOR: 1.95), or married (aOR: 1.21). Having at least one personal doctor (aOR: 2.86) was a strong predictor of PSA screening.
[CONCLUSION] Men with poor mental health are less likely to undergo PSA screening. Addressing mental health barriers is essential to improve preventive care. Integrated care models with mental health support may reduce disparities and enhance prostate cancer outcomes in this population.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.